Charlie Deeter
Head of Business Development at Arma Biosciences- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Arma Biosciences
-
Medical Device
-
1 - 100 Employee
-
Head of Business Development
-
Dec 2022 - Present
-
-
-
Polsky Center at the University of Chicago
-
United States
-
Higher Education
-
1 - 100 Employee
-
Innovation Fund Associate - George Schultz Innovation Fund
-
Jan 2022 - Dec 2022
• Selected from a highly competitive applicant pool, which included law, business, sciences, undergraduate, and medical school students, to evaluate early-stage technologies through a learn-by-doing apprenticeship model • Elected as leader of diligence team to assess a medical device technology and ensure deal deadlines were achieved, 88% of the investment committee agreed with team’s decision to provide funding • $20M venture fund investing in technologies developed at The University of Chicago, Argonne National Laboratory, Fermilab, and Marine Biological Laboratory Show less
-
-
-
Jaguar Gene Therapy
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Operations Intern
-
May 2022 - Nov 2022
• Centralized an inventory strategy for predicting raw material levels, recommending inventory changes to over 70% of items • Discovered $4M in inactive raw materials in stock and partnered with resellers to structure consumables repurchase program • Gained experience with gene therapy manufacturing, GMP setup, regulatory, fundraising, and pre-clinical supply chain planning • Collaborated with gene therapy leaders from Avexis (acquired by Novartis for $9B as one of the first gene therapy successes) and top tier funded company including investments from ARCH Venture Partners, Goldman Sachs, Eli Lilly, and Deerfield Show less
-
-
-
UChicago Medicine
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Clinical Trials Strategy Consultant
-
Jul 2022 - Sep 2022
• Built key performance dashboards and benchmarks to monitor current clinical trial activation timelines to maintain NCI designation, identifying potential strategies to decrease cycle times by 20% • Enhanced historical data to quantify CPT code frequencies and average cost for improved gyno-oncology clinical trial budgeting • Formulated financial models to drive a centralized staffing change to decrease overhead costs across all clinical trials • Built key performance dashboards and benchmarks to monitor current clinical trial activation timelines to maintain NCI designation, identifying potential strategies to decrease cycle times by 20% • Enhanced historical data to quantify CPT code frequencies and average cost for improved gyno-oncology clinical trial budgeting • Formulated financial models to drive a centralized staffing change to decrease overhead costs across all clinical trials
-
-
-
Agilent Technologies
-
Biotechnology Research
-
700 & Above Employee
-
Product Specialist, Capital Equipment
-
Mar 2018 - Jul 2021
• Promoted to Product Specialist. • Lead negotiations of over $12M instrumentation, service, and consumables deals (60+ deals in total). • Grew revenue by more than 50% in Southeast Region (NC, SC, TN, GA, FL, MS, and AL) while exceeding target revenue. • Awarded the 2019 High Achievers Club, which is given to the top 2% performers. • Took on stretch projects including expanding geography to NY and NJ Region. • Successful results driven by teamwork and strategic relationship management execution. • Coordinated a team including subject matter experts from product marketing, scientific applications, and inside sales to drive value for target customers. • Recognized in Cilenti et al. Scientific Reports. 2020 exemplifying collaborative mindset. • Author in Elsakr et al. Journal of Visualized Experiments. 2019 for strategic partnership in developing 3-D cell analysis applications. Show less
-
-
-
Seahorse Bioscience, a part of Agilent Technologies
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Sales Development Representative
-
Apr 2016 - Feb 2018
• Promoted to position following the $235M acquisition of Seahorse Bioscience located in Boston, MA. • Supported over $22M and over 90 deals in emerging functional metabolism and cell analysis space through opportunity generation, lead qualification, and deal closing. • Ranked Best Sales Development Representative in 2016 and 2017. • Developed knowledge of global field sales organization, revenue forecasting, new business generation, and target customers in cancer, immunotherapy, and stem cell research fields. • Worked cross functionally with Product Managers to position products at industry workshops and target strategic accounts. • Built relationships in biotech, biopharma, and academic accounts. Show less
-
-
-
Agilent Technologies
-
Biotechnology Research
-
700 & Above Employee
-
Field Service Engineer
-
Feb 2014 - May 2016
• Hired into Undergraduate New Hire Program starting in Chicago, IL. • Delivered technical service on chromatography-based lab instruments to improve reliability and productivity. • Collaborated with sales, supply chain, and management to bring the highest quality of service to customers. • Developed strong relationships in academia, pharmaceuticals, energy, and food industries by engaging customers to meet their needs. • Hired into Undergraduate New Hire Program starting in Chicago, IL. • Delivered technical service on chromatography-based lab instruments to improve reliability and productivity. • Collaborated with sales, supply chain, and management to bring the highest quality of service to customers. • Developed strong relationships in academia, pharmaceuticals, energy, and food industries by engaging customers to meet their needs.
-
-
-
Centers for Disease Control and Prevention
-
United States
-
Government Administration
-
700 & Above Employee
-
Biological Laboratory Technician/Aide
-
Jun 2011 - Aug 2011
• Selected as one of two interns from a national applicant pool located in Fort Collins, CO. • Helped develop DNA-based vaccines for dengue virus, yellow fever, and West Nile virus in the laboratory of Dr. Jeff Chang. • Implemented experiments and reported lab data so the team could make conclusions and direct future research. • Selected as one of two interns from a national applicant pool located in Fort Collins, CO. • Helped develop DNA-based vaccines for dengue virus, yellow fever, and West Nile virus in the laboratory of Dr. Jeff Chang. • Implemented experiments and reported lab data so the team could make conclusions and direct future research.
-
-
Education
-
The University of Chicago Booth School of Business
Master of Business Administration - Full Time MBA -
University of Kansas
Bachelor of Arts (B.A.), Chemistry